When:
March 22, 2018 all-day
2018-03-22T00:00:00+01:00
2018-03-23T00:00:00+01:00

8AM – Room open for seating (Breakfast will not be provided)

Introduction – 8:30AM – 9:30 AM

8:30 – 9:00 AM Welcome and Workshop Objectives – Mirjam Luijten, RIVM, The Netherlands 

9:00 – 9:30 AM Overview of the GTTC – Structure, Purpose, and Recent Initiatives – Paul White, Health Canada, Canada 


Session I: Next Generation Assessment of Genomic Damage – “The Clean Sheet” 

9:30 -10:30 AM Path Forward for Genetic Toxicity Assessment – Kerry Dearfield, USDA (retired), USA

10:30 – 11:00 AM Break

11:00 – 12:00 PM The New Strategy in Practice: Case Study Examples – Veronique Thybaud, Sanofi, France & Nicholas Ball, Dow, Switzerland 

12:00 – 1:00 PM The Clean Sheet Strategy in Practice: Guided Discussion – Mirjam Luijten, RIVM, The Netherlands 

1:00 – 2:00 PM Lunch held in Mensa


Session II: Mode of Action Determination in Applied Genetic Toxicology 

2:00 – 2:30 PM Incorporating Mode of Action into Genetic Toxicity Assessment – Roland Frötschl, BfArM, Germany 

2:30 – 3:00 PM Novel Approaches and Technologies to Assess Genotoxic Modes of Action – Stefan Pfuhler, Procter & Gamble, USA 

3:00 – 3:30 PM Break

3:30 – 4:00 PM Genetic Toxicity Mini-Adverse Outcome Pathways (mini-AOPs) – Azeddine Elhajouji, Novartis, Switzerland 

4:00 – 5:00 PM Guided Discussion on Genotoxic Modes of Action – Maik Schuler, Pfizer, USA